Florida Board of Pharmacy Charges Against Misir Drugs LLC

Misir Drugs, LLC, PH 25701 – Naples, FL
 Case No. 2013-05486. PCP – Mesaros/Glass

Count One: Respondent violated Section 465.023(1)(c), F.S. (2012), by violating Rule 64B16-
28.108(3)(e), F.A.C., which requires the label on the immediate container of a repackaged product or a
multiple unit prepackaged drug product shall include the expiration date of the enclosed medication.
Count Two: Respondent violated Section 465.023(1)(c), F.S. (2012), by violating Rule 64B16-
28.108(3)(f), F.A.C., which requires the label on the immediate container of a repackaged product or a
multiple unit prepackaged drug product shall include the lot number of the medication enclosed within.
Count Three: Respondent violated Section 465.023(1)(c), F.S. (2012), by violating Section 456.42(2),
F.S. (2012), by filling and dispensing prescriptions for controlled substances on non-Department
approved counterfeit-proof prescription pads.
Count Four: Respondent violated Section 465.023(1)(c), F.S. (2012), by violating Section 893.07(2),
F.S. (2012), by failing to properly complete DEA Form 222.
Count Five: Respondent violated Section 465.023(1)(c), F.S. (2012), by violating Rule 64B16-28.140(4)
F.A.C., by failing to properly maintain compounding records.

This case was pulled by the Department.
quoted from Minutes of December 3-4, 2013